TSC-22 (TGF-&bgr; Stimulated Clone-22): A Novel Molecular Target for Differentiation-Inducing Therapy in Salivary Gland Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|6|521-529

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.6, 2004-09, pp. : 521-529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Ideas of Gene Therapy for Atherosclerosis: Modulation of Cellular Signal Transduction of TGF-&bgr; Family

By  

Current Pharmaceutical Design, Vol. 12, Iss. 7, 2006-03 ,pp. : 877-886

Bentham Science Publishers

Access to resources Recommend Favorite

Differentiation-Inducing Therapy for Solid Tumors

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 379-385

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines and Invertebrates: TGF-&bgr; and PDGF

By  

Current Pharmaceutical Design, Vol. 12, Iss. 24, 2006-08 ,pp. : 3025-3031

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the TGF-&bgr; Superfamily and their Clinical Applications

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-11 ,pp. : 1255-1261

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Tolerance and TGF-&bgr; -Producing Cells

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 3, 2006-01 ,pp. : 179-190

Bentham Science Publishers

Access to resources Recommend Favorite